OTC · PVTTF
Pivotal Therapeutics Inc.
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
Loading market information…
OTC · MMNFF · USD
Stock price, earnings
Quote as of Feb 7, 2024, 02:32 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow MedMen Enterprises Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
MedMen Enterprises Inc., along with its associated entities, operates as a cannabis enterprise throughout the United States. The company manages the entire process for both recreational and medicinal cannabis, from cultivation and manufacturing to distribution and direct retail sales. Its products are sold under the specific brand names MedMen Red and LuxLyte. As of December 25, 2021, its retail footprint included 29 stores spread across California, Florida, Nevada, Illinois, Arizona, Massachusetts, and New York. The primary corporate offices for MedMen Enterprises Inc. are situated in Culver City, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2022 | Nov 9, 2021 | -$0.06-500.0% vs estimate | $39.81M+18.47% vs estimate |
|---|
| Q4 2021 | Sep 23, 2021 | -$0.06-50.0% vs estimate | $48.68M+44.87% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
$0.00+$0.00 (0.0%)
Advanced Proteome Therapeutics Corporation: Healthcare · Biotechnology.
$0.00-$0.00 (-90.0%)
RedHawk Holdings Corp.: Healthcare · Medical - Devices.
$0.00+$0.00 (+400.0%)
QuantRx Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 87.5% below the high.
$0.00+$0.00 (+29,900.0%)
Miravant Medical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
PotNetwork Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Predictive Technology Group, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Eden Empire Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.91% below the high.
